Borregaard ASA
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company develops, produces, and sells biopolymers and biovanillin for agrochemicals, batteries, industrial binders, and construct… Read more
Borregaard ASA (BRRDF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.071x
Based on the latest financial reports, Borregaard ASA (BRRDF) has a cash flow conversion efficiency ratio of 0.071x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($42.35 Million) by net assets ($594.77 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Borregaard ASA - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Borregaard ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Borregaard ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Borregaard ASA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392
|
0.010x |
|
Betsson AB (publ)
PINK:BTSNY
|
0.026x |
|
Jereissati Participações S.A.
SA:IGTI11
|
0.029x |
|
Ryman Healthcare Limited
PINK:RHCGF
|
0.040x |
|
Hakuhodo DY Holdings Inc
OTCGREY:HKUOF
|
0.072x |
|
Jonjee Hi-tech Industrial and Commercial Holding Co Ltd
SHG:600872
|
0.045x |
|
Betta Pharmaceuticals Co Ltd
SHE:300558
|
0.038x |
|
Innodata Inc
NASDAQ:INOD
|
0.193x |
Annual Cash Flow Conversion Efficiency for Borregaard ASA (2009–2024)
The table below shows the annual cash flow conversion efficiency of Borregaard ASA from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $5.09 Billion | $1.07 Billion | 0.210x | -34.30% |
| 2023-12-31 | $4.89 Billion | $1.56 Billion | 0.319x | +93.14% |
| 2022-12-31 | $4.45 Billion | $735.00 Million | 0.165x | -50.24% |
| 2021-12-31 | $4.31 Billion | $1.43 Billion | 0.332x | +41.71% |
| 2020-12-31 | $3.78 Billion | $886.00 Million | 0.235x | +16.55% |
| 2019-12-31 | $3.46 Billion | $697.00 Million | 0.201x | +19.75% |
| 2018-12-31 | $3.32 Billion | $558.00 Million | 0.168x | -35.46% |
| 2017-12-31 | $3.00 Billion | $780.00 Million | 0.260x | -34.66% |
| 2016-12-31 | $2.71 Billion | $1.08 Billion | 0.398x | +45.86% |
| 2015-12-31 | $2.06 Billion | $563.00 Million | 0.273x | -11.27% |
| 2014-12-31 | $1.95 Billion | $600.00 Million | 0.308x | +5.81% |
| 2013-12-31 | $1.86 Billion | $540.00 Million | 0.291x | -8.28% |
| 2012-12-31 | $1.74 Billion | $551.00 Million | 0.317x | -33.54% |
| 2011-12-31 | $1.12 Billion | $536.00 Million | 0.477x | +7.07% |
| 2010-12-31 | $1.01 Billion | $452.00 Million | 0.446x | +19.84% |
| 2009-12-31 | $1.35 Billion | $504.00 Million | 0.372x | -- |